{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:36:49Z","timestamp":1787996209021,"version":"build-2784847793"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jiac.2026.102923","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:35:56Z","timestamp":1770222956000},"page":"102923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Definitive cefepime versus carbapenems for bacteremia caused by Enterobacterales with a risk of chromosomal AmpC production in children"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0211-0661","authenticated-orcid":false,"given":"Takashi","family":"Shoji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8184-6873","authenticated-orcid":false,"given":"Yuto","family":"Otsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuho","family":"Horikoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.102923_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2026.102923_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/diseases12030052","article-title":"Wild-type AmpC beta-lactamase-producing Enterobacterales are a risk factor for empirical treatment failure in patients with bloodstream infection","volume":"12","author":"Vassallo","year":"2024","journal-title":"Diseases"},{"key":"10.1016\/j.jiac.2026.102923_bib3","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.2147\/IDR.S473789","article-title":"Mortality and risk factors of death in patients with AmpC \u03b2-lactamase producing Enterobacterales bloodstream infection: a cohort study","volume":"17","author":"Silva","year":"2024","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jiac.2026.102923_bib4","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/cid\/ciz173","article-title":"A primer on AmpC \u03b2-lactamases: necessary knowledge for an increasingly multidrug-resistant world","volume":"69","author":"Tamma","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.102923_bib5","doi-asserted-by":"crossref","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.102923_bib6","doi-asserted-by":"crossref","first-page":"ofaf413","DOI":"10.1093\/ofid\/ofaf413","article-title":"Cefepime versus carbapenem therapy for the treatment of invasive infections with inducible chromosomal AmpC-Producing enterobacterales: a systematic review and meta-analysis","volume":"12","author":"Cheo","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2026.102923_bib7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/00006454-200210000-00010","article-title":"Clinical implications of inducible beta-lactamase activity in Gram-negative bacteremia in children","volume":"21","author":"Boyle","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2026.102923_bib8","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1128\/JCM.43.6.2551-2558.2005","article-title":"Practical methods using boronic acid compounds for identification of class C \u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli","volume":"43","author":"Yagi","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2026.102923_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10096-012-1772-x","article-title":"Comparison of different phenotypic assays for the detection of extended-spectrum \u03b2-lactamase production by inducible AmpC-producing Gram-negative Bacilli","volume":"32","author":"Willems","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2026.102923_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/cid\/cit395","article-title":"The use of cefepime for treating AmpC \u03b2-lactamase\u2013producing enterobacteriaceae","volume":"57","author":"Tamma","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.102923_bib11","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/cid\/ciu182","article-title":"Cefepime vs other antibacterial agents for the treatment of enterobacter species bacteremia","volume":"58","author":"Siedner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.102923_bib12","doi-asserted-by":"crossref","first-page":"ofad034","DOI":"10.1093\/ofid\/ofad034","article-title":"High-dose cefepime vs carbapenems for bacteremia caused by Enterobacterales with moderate to high risk of clinically significant AmpC \u03b2-lactamase production","volume":"10","author":"Coyne","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2026.102923_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijid.2023.07.004","article-title":"Cefepime vs carbapenems for treating third-generation cephalosporin-resistant AmpC \u03b2-lactamase-hyperproducing Enterobacterales bloodstream infections: a multicenter retrospective study","volume":"134","author":"Hoellinger","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2026.102923_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10096-023-04715-5","article-title":"Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections","volume":"43","author":"Herrmann","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2026.102923_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jac\/dkv346","article-title":"Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by enterobacter, citrobacter, or serratia species: a systematic review with meta-analysis","volume":"71","author":"Harris","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2026.102923_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/29.suppl_A.1","article-title":"Factors involved in the enhanced efficacy against Gram-negative bacteria of fourth-generation cephalosporins","volume":"29","author":"Hancock","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2026.102923_bib17","doi-asserted-by":"crossref","first-page":"ofx113","DOI":"10.1093\/ofid\/ofx113","article-title":"The dose-dependent efficacy of cefepime in the empiric management of febrile neutropenia: a systematic review and meta-analysis","volume":"4","author":"Andreatos","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2026.102923_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jpeds.2010.03.023","article-title":"Efficacy and safety of cefepime in pediatric patients: a systematic review and meta-analysis","volume":"157","author":"Adderson","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.jiac.2026.102923_bib19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/pathogens11070722","article-title":"The predominance of Klebsiella aerogenes among carbapenem-resistant enterobacteriaceae infections in Japan","volume":"11","author":"Kamio","year":"2022","journal-title":"Pathogens"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:32:28Z","timestamp":1772022748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26000218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1341321X26000218"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102923","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definitive cefepime versus carbapenems for bacteremia caused by Enterobacterales with a risk of chromosomal AmpC production in children","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102923"}}